Annual EBITDA:
-$183.47M+$190.33M(+50.92%)Summary
- As of today, NVAX annual EBITDA is -$183.47 million, with the most recent change of +$190.33 million (+50.92%) on December 31, 2024.
- During the last 3 years, NVAX annual EBITDA has risen by +$1.49 billion (+89.04%).
- NVAX annual EBITDA is now -4285.13% below its all-time high of -$4.18 million, reached on December 31, 1999.
Performance
NVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$120.53M-$413.37M(-77.42%)Summary
- As of today, NVAX quarterly EBITDA is $120.53 million, with the most recent change of -$413.37 million (-77.42%) on June 30, 2025.
- Over the past year, NVAX quarterly EBITDA has dropped by -$59.33 million (-32.98%).
- NVAX quarterly EBITDA is now -77.42% below its all-time high of $533.91 million, reached on March 31, 2025.
Performance
NVAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$495.57M-$59.33M(-10.69%)Summary
- As of today, NVAX TTM EBITDA is $495.57 million, with the most recent change of -$59.33 million (-10.69%) on June 30, 2025.
- Over the past year, NVAX TTM EBITDA has increased by +$723.82 million (+317.11%).
- NVAX TTM EBITDA is now -10.69% below its all-time high of $554.89 million, reached on March 31, 2025.
Performance
NVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +50.9% | -33.0% | +317.1% |
| 3Y3 Years | +89.0% | +124.3% | +135.2% |
| 5Y5 Years | -48.2% | +993.3% | +294.4% |
NVAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +89.0% | -77.4% | +143.2% | -10.7% | +139.6% |
| 5Y | 5-Year | -48.2% | +89.0% | -77.4% | +114.7% | -10.7% | +129.5% |
| All-Time | All-Time | -4285.1% | +89.0% | -77.4% | +114.7% | -10.7% | +129.5% |
NVAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $120.53M(-77.4%) | $495.57M(-10.7%) |
| Mar 2025 | - | $533.91M(+1098.4%) | $554.89M(+613.6%) |
| Dec 2024 | -$183.47M(+50.9%) | -$53.48M(+49.3%) | -$108.04M(+50.1%) |
| Sep 2024 | - | -$105.40M(-158.6%) | -$216.35M(+5.2%) |
| Jun 2024 | - | $179.86M(+239.4%) | -$228.25M(+32.3%) |
| Mar 2024 | - | -$129.03M(+20.2%) | -$337.06M(+30.8%) |
| Dec 2023 | -$373.80M(+39.3%) | -$161.79M(-37.9%) | -$487.39M(+2.2%) |
| Sep 2023 | - | -$117.29M(-265.1%) | -$498.29M(+6.8%) |
| Jun 2023 | - | $71.06M(+125.4%) | -$534.62M(+51.5%) |
| Mar 2023 | - | -$279.36M(-61.8%) | -$1.10B(-82.2%) |
| Dec 2022 | -$615.68M(+63.2%) | -$172.69M(-12.4%) | -$604.71M(+51.7%) |
| Sep 2022 | - | -$153.63M(+69.0%) | -$1.25B(+10.9%) |
| Jun 2022 | - | -$496.11M(-327.9%) | -$1.41B(-12.5%) |
| Mar 2022 | - | $217.71M(+126.5%) | -$1.25B(+25.6%) |
| Dec 2021 | -$1.67B(-309.1%) | -$820.87M(-167.4%) | -$1.68B(-62.9%) |
| Sep 2021 | - | -$306.95M(+9.8%) | -$1.03B(-12.6%) |
| Jun 2021 | - | -$340.39M(-59.9%) | -$916.85M(-55.4%) |
| Mar 2021 | - | -$212.90M(-23.9%) | -$589.95M(-47.9%) |
| Dec 2020 | -$409.13M(-230.5%) | -$171.89M(+10.3%) | -$398.94M(-56.5%) |
| Sep 2020 | - | -$191.66M(-1320.4%) | -$254.90M(-229.5%) |
| Jun 2020 | - | -$13.49M(+38.4%) | -$77.35M(+21.5%) |
| Mar 2020 | - | -$21.89M(+21.4%) | -$98.49M(+14.2%) |
| Dec 2019 | -$123.80M(+25.3%) | -$27.85M(-97.3%) | -$114.83M(+12.5%) |
| Sep 2019 | - | -$14.12M(+59.2%) | -$131.28M(+16.2%) |
| Jun 2019 | - | -$34.63M(+9.4%) | -$156.65M(+2.9%) |
| Mar 2019 | - | -$38.23M(+13.7%) | -$161.41M(+1.8%) |
| Dec 2018 | -$165.76M(-2.4%) | -$44.30M(-12.2%) | -$164.40M(+0.5%) |
| Sep 2018 | - | -$39.48M(-0.2%) | -$165.29M(-1.2%) |
| Jun 2018 | - | -$39.39M(+4.5%) | -$163.37M(-0.3%) |
| Mar 2018 | - | -$41.23M(+8.8%) | -$162.88M(-1.9%) |
| Dec 2017 | -$161.89M(+37.9%) | -$45.20M(-20.3%) | -$159.88M(+3.7%) |
| Sep 2017 | - | -$37.56M(+3.4%) | -$166.06M(+12.1%) |
| Jun 2017 | - | -$38.89M(-1.7%) | -$189.03M(+15.6%) |
| Mar 2017 | - | -$38.23M(+25.6%) | -$223.86M(+13.4%) |
| Dec 2016 | -$260.61M(-72.3%) | -$51.38M(+15.1%) | -$258.50M(+9.0%) |
| Sep 2016 | - | -$60.52M(+17.9%) | -$284.17M(-11.4%) |
| Jun 2016 | - | -$73.73M(-1.2%) | -$255.15M(-27.2%) |
| Mar 2016 | - | -$72.87M(+5.4%) | -$200.56M(-33.1%) |
| Dec 2015 | -$151.25M(-90.8%) | -$77.06M(-144.6%) | -$150.71M(-45.2%) |
| Sep 2015 | - | -$31.50M(-64.7%) | -$103.77M(-14.1%) |
| Jun 2015 | - | -$19.13M(+16.9%) | -$90.91M(-2.6%) |
| Mar 2015 | - | -$23.02M(+23.5%) | -$88.61M(-13.1%) |
| Dec 2014 | -$79.27M(-63.3%) | -$30.11M(-61.5%) | -$78.37M(-27.8%) |
| Sep 2014 | - | -$18.64M(-10.7%) | -$61.32M(-7.1%) |
| Jun 2014 | - | -$16.84M(-31.8%) | -$57.24M(-9.1%) |
| Mar 2014 | - | -$12.78M(+2.2%) | -$52.48M(-6.6%) |
| Dec 2013 | -$48.54M(-73.4%) | -$13.07M(+10.3%) | -$49.21M(-12.6%) |
| Sep 2013 | - | -$14.56M(-20.6%) | -$43.70M(-21.6%) |
| Jun 2013 | - | -$12.07M(-27.0%) | -$35.95M(-22.3%) |
| Mar 2013 | - | -$9.51M(-25.7%) | -$29.39M(-9.6%) |
| Dec 2012 | -$28.00M(-40.2%) | -$7.57M(-11.2%) | -$26.81M(-19.0%) |
| Sep 2012 | - | -$6.80M(-23.5%) | -$22.53M(-21.6%) |
| Jun 2012 | - | -$5.51M(+20.5%) | -$18.53M(-7.7%) |
| Mar 2012 | - | -$6.93M(-110.9%) | -$17.20M(+0.8%) |
| Dec 2011 | -$19.97M(+46.2%) | -$3.29M(-17.3%) | -$17.33M(+14.5%) |
| Sep 2011 | - | -$2.80M(+33.0%) | -$20.26M(+26.2%) |
| Jun 2011 | - | -$4.18M(+40.8%) | -$27.45M(+13.6%) |
| Mar 2011 | - | -$7.06M(-13.6%) | -$31.79M(+11.4%) |
| Dec 2010 | -$37.09M | -$6.21M(+37.8%) | -$35.89M(+21.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$10.00M(-17.4%) | -$45.71M(-4.7%) |
| Jun 2010 | - | -$8.52M(+23.7%) | -$43.68M(-2.3%) |
| Mar 2010 | - | -$11.16M(+30.4%) | -$42.68M(-11.2%) |
| Dec 2009 | -$36.19M(-8.1%) | -$16.04M(-101.3%) | -$38.37M(-22.9%) |
| Sep 2009 | - | -$7.96M(-5.9%) | -$31.23M(+5.3%) |
| Jun 2009 | - | -$7.52M(-9.9%) | -$32.98M(+0.9%) |
| Mar 2009 | - | -$6.84M(+23.1%) | -$33.30M(+0.5%) |
| Dec 2008 | -$33.47M(-22.4%) | -$8.90M(+8.5%) | -$33.47M(-21.2%) |
| Sep 2008 | - | -$9.72M(-24.0%) | -$27.61M(-3.0%) |
| Jun 2008 | - | -$7.84M(-11.8%) | -$26.80M(+0.8%) |
| Mar 2008 | - | -$7.01M(-130.2%) | -$27.02M(+3.0%) |
| Dec 2007 | -$27.34M(-26.9%) | -$3.04M(+65.8%) | -$27.85M(+1.1%) |
| Sep 2007 | - | -$8.91M(-10.5%) | -$28.16M(-14.3%) |
| Jun 2007 | - | -$8.06M(-2.8%) | -$24.64M(-8.5%) |
| Mar 2007 | - | -$7.84M(-134.1%) | -$22.71M(-20.2%) |
| Dec 2006 | -$21.55M(-33.8%) | -$3.35M(+37.9%) | -$18.89M(-374.7%) |
| Sep 2006 | - | -$5.39M(+12.1%) | -$3.98M(-2807.5%) |
| Jun 2006 | - | -$6.13M(-52.6%) | $147.00K(-93.0%) |
| Mar 2006 | - | -$4.02M(-134.8%) | $2.09M(+263.6%) |
| Dec 2005 | -$16.11M(+49.4%) | $11.56M(+1015.5%) | -$1.28M(+94.1%) |
| Sep 2005 | - | -$1.26M(+69.8%) | -$21.86M(+1.1%) |
| Jun 2005 | - | -$4.19M(+43.3%) | -$22.11M(+9.9%) |
| Mar 2005 | - | -$7.39M(+18.1%) | -$24.55M(-14.7%) |
| Dec 2004 | -$31.85M(-114.2%) | -$9.02M(-496.5%) | -$21.41M(-41.4%) |
| Sep 2004 | - | -$1.51M(+77.2%) | -$15.14M(+7.0%) |
| Jun 2004 | - | -$6.63M(-56.1%) | -$16.28M(-16.3%) |
| Mar 2004 | - | -$4.25M(-54.6%) | -$13.99M(+5.9%) |
| Dec 2003 | -$14.87M(+27.2%) | -$2.75M(-3.7%) | -$14.87M(+6.7%) |
| Sep 2003 | - | -$2.65M(+39.1%) | -$15.93M(+18.2%) |
| Jun 2003 | - | -$4.35M(+15.1%) | -$19.48M(+4.4%) |
| Mar 2003 | - | -$5.12M(-34.4%) | -$20.36M(+0.3%) |
| Dec 2002 | -$20.42M(-106.5%) | -$3.81M(+38.5%) | -$20.42M(-8.9%) |
| Sep 2002 | - | -$6.20M(-18.4%) | -$18.75M(-33.3%) |
| Jun 2002 | - | -$5.24M(-1.1%) | -$14.06M(-46.9%) |
| Mar 2002 | - | -$5.18M(-142.3%) | -$9.58M(-66.1%) |
| Dec 2001 | -$9.89M(+18.6%) | -$2.14M(-41.2%) | -$5.77M(+31.6%) |
| Sep 2001 | - | -$1.51M(-102.5%) | -$8.43M(+17.3%) |
| Jun 2001 | - | -$747.00K(+45.4%) | -$10.19M(+16.2%) |
| Mar 2001 | - | -$1.37M(+71.5%) | -$12.16M(-0.1%) |
| Dec 2000 | -$12.15M(-190.3%) | -$4.80M(-46.6%) | -$12.15M(-45.5%) |
| Sep 2000 | - | -$3.27M(-20.2%) | -$8.35M(-25.1%) |
| Jun 2000 | - | -$2.72M(-101.3%) | -$6.68M(-40.5%) |
| Mar 2000 | - | -$1.35M(-35.3%) | -$4.75M(-13.2%) |
| Dec 1999 | -$4.18M(+14.1%) | -$1.00M(+37.5%) | -$4.20M(+12.5%) |
| Sep 1999 | - | -$1.60M(-100.0%) | -$4.80M(-9.1%) |
| Jun 1999 | - | -$800.00K(0.0%) | -$4.40M(+8.3%) |
| Mar 1999 | - | -$800.00K(+50.0%) | -$4.80M(0.0%) |
| Dec 1998 | -$4.87M(-7.3%) | -$1.60M(-33.3%) | -$4.80M(-14.3%) |
| Sep 1998 | - | -$1.20M(0.0%) | -$4.20M(-2.4%) |
| Jun 1998 | - | -$1.20M(-50.0%) | -$4.10M(+2.4%) |
| Mar 1998 | - | -$800.00K(+20.0%) | -$4.20M(+4.5%) |
| Dec 1997 | -$4.54M(+12.8%) | -$1.00M(+9.1%) | -$4.40M(+13.7%) |
| Sep 1997 | - | -$1.10M(+15.4%) | -$5.10M(-4.1%) |
| Jun 1997 | - | -$1.30M(-30.0%) | -$4.90M(-2.1%) |
| Mar 1997 | - | -$1.00M(+41.2%) | -$4.80M(0.0%) |
| Dec 1996 | -$5.21M(+19.6%) | -$1.70M(-88.9%) | -$4.80M(-54.8%) |
| Sep 1996 | - | -$900.00K(+25.0%) | -$3.10M(-40.9%) |
| Jun 1996 | - | -$1.20M(-20.0%) | -$2.20M(-120.0%) |
| Mar 1996 | - | -$1.00M | -$1.00M |
| Dec 1995 | -$6.47M | - | - |
FAQ
- What is Novavax, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Novavax, Inc.?
- What is Novavax, Inc. annual EBITDA year-on-year change?
- What is Novavax, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Novavax, Inc.?
- What is Novavax, Inc. quarterly EBITDA year-on-year change?
- What is Novavax, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Novavax, Inc.?
- What is Novavax, Inc. TTM EBITDA year-on-year change?
What is Novavax, Inc. annual EBITDA?
The current annual EBITDA of NVAX is -$183.47M
What is the all-time high annual EBITDA for Novavax, Inc.?
Novavax, Inc. all-time high annual EBITDA is -$4.18M
What is Novavax, Inc. annual EBITDA year-on-year change?
Over the past year, NVAX annual EBITDA has changed by +$190.33M (+50.92%)
What is Novavax, Inc. quarterly EBITDA?
The current quarterly EBITDA of NVAX is $120.53M
What is the all-time high quarterly EBITDA for Novavax, Inc.?
Novavax, Inc. all-time high quarterly EBITDA is $533.91M
What is Novavax, Inc. quarterly EBITDA year-on-year change?
Over the past year, NVAX quarterly EBITDA has changed by -$59.33M (-32.98%)
What is Novavax, Inc. TTM EBITDA?
The current TTM EBITDA of NVAX is $495.57M
What is the all-time high TTM EBITDA for Novavax, Inc.?
Novavax, Inc. all-time high TTM EBITDA is $554.89M
What is Novavax, Inc. TTM EBITDA year-on-year change?
Over the past year, NVAX TTM EBITDA has changed by +$723.82M (+317.11%)